retatrutide phase 2 obesity nejm 2023 jastreboff Trial: 48-Week Weight Loss Results Explained – Bolt Pharmacy NEJM on X: "Original Article:

This peptide is a master of regeneration, and its work extends to other parts of the body that show signs of aging or wear and tear

The original 2015 Cell Metabolism study demonstrated that intraperitoneal MOTS-c injections (5 mg/kg) in mice fed a high-fat diet prevented obesity and insulin resistance, with effects on fat mass, fasting glucose, and insulin sensitivity that rivaled pharmaceutical intervention [1]

CagriSema for weight management was submitted to the US Food and Drug Administration (FDA) in December 2025 based on the REDEFINE 1 and REDEFINE 2 trials

According to this PubMed report GHK-CU has been shown to: -Tighten loose skin and reverse thinning of aged skin -Repair protective skin barrier proteins -Improve skin firmness, elasticity, and clarity -Reduce fine lines, depth of wrinkles, and improve structure of aged skin -Smooth rough skin -Reduce photodamage, mottled hyperpigmentation, skin spots and lesions -Improve overall skin appearance -Stimulate wound healing -Protect skin cells from UV radiation -Reduce inflammation and free radical damage -Increase hair growth and thickness, enlarge hair follicle size TLDR: GHK-CU is used to repair and rejuventate your skin/hair while also protecting it from the things that are aging it

It requires intentional planning